Stay updated on Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.

Latest updates to the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page’s revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a maintenance or platform update rather than a change to the clinical trial information.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page software revision was updated to v3.4.3, replacing the previous v3.4.2. There are no observed changes to the clinical trial details, eligibility criteria, locations, or study results.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1. No substantive content changes are evident.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.